BioRestorative Therapies Inc BRTX Q1 2026 Earnings Narrower Loss Surprises Stock Rises 78 Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage FTI Consulting FCN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick Arbe Robotics Q4 2025 Earnings Narrowing Losses Amidst Market Skepticism C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage SDST Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase